Induction of LIFR Confers a Dormancy Phenotype in Breast Cancer Cells Disseminated to the Bone Marrow

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2016 Sep 20

PMID 27642788

Citations 150

Authors

Rachelle W Johnson

Elizabeth C Finger

Monica M Olcina

Marta Vilalta

Todd Aguilera

Yu Miao

Alyssa R Merkel

Joshua R Johnson

Julie A Sterling

Joy Y Wu

Amato J Giaccia

Affiliations

Soon will be listed here.

Abstract

Breast cancer cells frequently home to the bone marrow, where they may enter a dormant state before forming a bone metastasis. Several members of the interleukin-6 (IL-6) cytokine family are implicated in breast cancer bone colonization, but the role for the IL-6 cytokine leukaemia inhibitory factor (LIF) in this process is unknown. We tested the hypothesis that LIF provides a pro-dormancy signal to breast cancer cells in the bone. In breast cancer patients, LIF receptor (LIFR) levels are lower with bone metastases and are significantly and inversely correlated with patient outcome and hypoxia gene activity. Hypoxia also reduces the LIFR:STAT3:SOCS3 signalling pathway in breast cancer cells. Loss of the LIFR or STAT3 enables otherwise dormant breast cancer cells to downregulate dormancy-, quiescence- and cancer stem cell-associated genes, and to proliferate in and specifically colonize the bone, suggesting that LIFR:STAT3 signalling confers a dormancy phenotype in breast cancer cells disseminated to bone.

Citing Articles

Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.

Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K Mol Cancer. 2025; 24(1):47.

PMID: 39953555 PMC: 11829473. DOI: 10.1186/s12943-025-02250-9.

Parathyroid hormone-related protein levels and treatment outcomes in hypercalcemia of malignancy: a retrospective cohort study.

Kato K, Nakashima A, Kimura A, Maruyama Y, Ohkido I, Miyazaki Y JBMR Plus. 2025; 9(3):ziae178.

PMID: 39925622 PMC: 11807284. DOI: 10.1093/jbmrpl/ziae178.

Immunohistochemical expression of parathyroid hormone-related protein and ezrin in invasive breast carcinoma of no special type: a retrospective analysis.

Shalaby M, Dawoud M, Gadallah M, Abdou A Diagn Pathol. 2025; 20(1):8.

PMID: 39827339 PMC: 11742503. DOI: 10.1186/s13000-025-01598-2.

Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?.

Liu W, Kovacs A, Hou J Cells. 2024; 13(23).

PMID: 39682769 PMC: 11640528. DOI: 10.3390/cells13232022.

The Link Between the Gut Microbiome and Bone Metastasis.

Sevcikova A, Martiniakova M, Omelka R, Stevurkova V, Ciernikova S Int J Mol Sci. 2024; 25(22).

PMID: 39596154 PMC: 11593804. DOI: 10.3390/ijms252212086.

References

Biswas S, Nyman J, Alvarez J, Chakrabarti A, Ayres A, Sterling J . Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One. 2011; 6(11):e27090. PMC: 3214031. DOI: 10.1371/journal.pone.0027090. View

Nandy S, Arumugam A, Subramani R, Pedroza D, Hernandez K, Saltzstein E . MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway. Oncotarget. 2015; 6(19):17366-78. PMC: 4627314. DOI: 10.18632/oncotarget.3953. View

Wang N, Docherty F, Brown H, Reeves K, Fowles A, Lawson M . Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer. FASEB J. 2015; 29(8):3141-50. DOI: 10.1096/fj.14-266379. View

Zheng Y, Basel D, Chow S, Fong-Yee C, Kim S, Buttgereit F . Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone. Clin Exp Metastasis. 2014; 31(8):921-33. DOI: 10.1007/s10585-014-9680-3. View

Shachaf C, Kopelman A, Arvanitis C, Karlsson A, Beer S, Mandl S . MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 2004; 431(7012):1112-7. DOI: 10.1038/nature03043. View

Thomas R, Guise T, Yin J, Elliott J, Horwood N, Martin T . Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology. 1999; 140(10):4451-8. DOI: 10.1210/endo.140.10.7037. View

Sosa M, Bragado P, Aguirre-Ghiso J . Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014; 14(9):611-22. PMC: 4230700. DOI: 10.1038/nrc3793. View

Wetzler M, Talpaz M, Lowe D, Baiocchi G, Gutterman J, Kurzrock R . Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. Exp Hematol. 1991; 19(5):347-51. View

Gao H, Chakraborty G, Lee-Lim A, Mo Q, Decker M, Vonica A . The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012; 150(4):764-79. PMC: 3711709. DOI: 10.1016/j.cell.2012.06.035. View

10.

Kobayashi A, Okuda H, Xing F, Pandey P, Watabe M, Hirota S . Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med. 2011; 208(13):2641-55. PMC: 3244043. DOI: 10.1084/jem.20110840. View

11.

Razorenova O, Castellini L, Colavitti R, Edgington L, Nicolau M, Huang X . The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells. Mol Cell Biol. 2013; 34(4):739-51. PMC: 3911479. DOI: 10.1128/MCB.00644-12. View

12.

Kusuma N, Denoyer D, Eble J, Redvers R, Parker B, Pelzer R . Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int J Cancer. 2011; 130(3):555-66. DOI: 10.1002/ijc.26018. View

13.

Sims N, Johnson R . Leukemia inhibitory factor: a paracrine mediator of bone metabolism. Growth Factors. 2012; 30(2):76-87. DOI: 10.3109/08977194.2012.656760. View

14.

Lee H, Kim K . Suppression of HIF-1α by Valproic Acid Sustains Self-Renewal of Mouse Embryonic Stem Cells under Hypoxia In Vitro. Biomol Ther (Seoul). 2013; 20(3):280-5. PMC: 3794524. DOI: 10.4062/biomolther.2012.20.3.280. View

15.

Olcina M, Leszczynska K, Senra J, Isa N, Harada H, Hammond E . H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene. 2015; 35(6):793-9. PMC: 4753255. DOI: 10.1038/onc.2015.134. View

16.

Allan E, Hilton D, Brown M, Evely R, Yumita S, Metcalf D . Osteoblasts display receptors for and responses to leukemia-inhibitory factor. J Cell Physiol. 1990; 145(1):110-9. DOI: 10.1002/jcp.1041450116. View

17.

Rathjen P, Nichols J, Toth S, Edwards D, Heath J, Smith A . Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev. 1990; 4(12B):2308-18. DOI: 10.1101/gad.4.12b.2308. View

18.

Bragado P, Sosa M, Keely P, Condeelis J, Aguirre-Ghiso J . Microenvironments dictating tumor cell dormancy. Recent Results Cancer Res. 2012; 195:25-39. PMC: 3516301. DOI: 10.1007/978-3-642-28160-0_3. View

19.

Minn A, Gupta G, Siegel P, Bos P, Shu W, Giri D . Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436(7050):518-24. PMC: 1283098. DOI: 10.1038/nature03799. View

20.

Generali D, Berruti A, Brizzi M, Campo L, Bonardi S, Wigfield S . Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res. 2006; 12(15):4562-8. DOI: 10.1158/1078-0432.CCR-05-2690. View